About
Bio
Designed for professionals in the life sciences and related industries. Provides comprehensive coverage of information technology systems, products and services for specific life science applications. Focuses on bio-IT technology, business trends and forecasts, technology selection, government policy and regulations and case studies.
The publication focuses on: Genomic analysis: next-generation sequencing, genome-wide association mapping, and data integration. Discovery informatics: collection, analysis and workflows of compound, microarray, proteomic, imaging, and pre-clinical and clinical data. Systems biology: gene, protein, metabolite, and network/pathway information. Computational modeling: biosimulations of pathways, drug action, and clinical data. Predictiveness: in vitro assays, biomarkers, and animal models. Cheminformatics: structure-based drug design, compound characterization, ADME-Tox, and selectivity. Correlation of biological data: disease diagnosis, patient selection, and drug response. Target data: biological, pathway, interaction, patent, and family. IT infrastructure: grid computing and high-performance computing. Text mining: internal documents and published literature. Semantic web: next-generation data sharing and social networking. Clinical research: electronic data capture, patient recruitment, and adaptive trials. Pharmacogenomics: diagnostics for therapeutics, patient stratification.
Bio-IT World DOES ACCEPT article submissions. They cannot be editorial and are best discussed on a case by case basis with Editor-in-Chief.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United States of America
Frequency
upgrade
Circulation
upgrade
Sectors
Biotechnology, Biotechnology Industry, Life Sciences
Bio
Designed for professionals in the life sciences and related industries. Provides comprehensive coverage of information technology systems, products and services for specific life science applications. Focuses on bio-IT technology, business trends and forecasts, technology selection, government policy and regulations and case studies. The publication focuses on: Genomic analysis: next-generation sequencing, genome-wide association mapping, and data integration. Discovery informatics: collection, analysis and workflows of compound, microarray, proteomic, imaging, and pre-clinical and clinical data. Systems biology: gene, protein, metabolite, and network/pathway information. Computational modeling: biosimulations of pathways, drug action, and clinical data. Predictiveness: in vitro assays, biomarkers, and animal models. Cheminformatics: structure-based drug design, compound characterization, ADME-Tox, and selectivity. Correlation of biological data: disease diagnosis, patient selection, and drug response. Target data: biological, pathway, interaction, patent, and family. IT infrastructure: grid computing and high-performance computing. Text mining: internal documents and published literature. Semantic web: next-generation data sharing and social networking. Clinical research: electronic data capture, patient recruitment, and adaptive trials. Pharmacogenomics: diagnostics for therapeutics, patient stratification. Bio-IT World DOES ACCEPT article submissions. They cannot be editorial and are best discussed on a case by case basis with Editor-in-Chief.
Website
Social media
Location
Frequency
Circulation
Sectors
Biotechnology, Biotechnology Industry, Life Sciences
Most recent articles by Bio-IT World
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Bio-IT World
-
SSTAT News
STAT News covers health, medicine and life science news. In specific it offers coverage on the business of making medicines, health tech, science, and public health.
ViewSScientific AmericanEstablished in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.
ViewNNew ScientistNew Scientist is one of the world’s most popular weekly science and technology publications. The weekly print magazine covers international scientific news and explores big-picture questions about life, the universe, and what it means to be human. Founded in 1956, it presents reporting on cutting-edge research, thoughtful features, and fresh ideas from across science and technology — from artificial intelligence to human health and fundamental physics.
ViewMMIT Technology ReviewEstablished in 1899 and written for venture capitalists and hi-tech executives as an informational source on innovative and improved technologies and their applications. Focuses on promoting the understanding of emerging technologies and their impact. Strives to promote the understanding of emerging technology and its impact on the world. Aims to promote the understanding of emerging technologies and to analyze their commercial, social and political impacts. Assists technology and business leaders including CXOs, entrepreneurs, researchers, venture capitalists and financiers as they drive the global economy.
ViewEEndpoints NewsEndpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).
ViewUse CisionOne to find more relevant outletsExplore journalists that write for Bio-IT World
-
D
-
A
-
P
Contact us to find more relevant journalistsDiscover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.